Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoma HMGIC fusion partner-like 1 protein (LHFPL1) is a tetraspan transmembrane protein encoded by the LHFPL1 gene, belonging to the lipoma HMGIC fusion partner (LHFP) family, which is a subset of the tetraspan transmembrane protein superfamily. While some LHFP-like genes are implicated in conditions such as deafness and lipoma due to gene fusion or mutations, the specific biological role and disease connections for LHFPL1 remain unclear. Alternatively spliced transcript variants of LHFPL1 have been detected, but their significance is not yet established[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoma HMGIC fusion partner-like 1 protein (LHFPL1).